Rebekka Jerjen, Nekma Meah, Lara Trindade de Carvalho, Dmitri Wall, Shyamalar Gunatheesan, Rodney Sinclair
{"title":"环孢素有效治疗decalvans毛囊炎:一个病例系列。","authors":"Rebekka Jerjen, Nekma Meah, Lara Trindade de Carvalho, Dmitri Wall, Shyamalar Gunatheesan, Rodney Sinclair","doi":"10.1111/ajd.13532","DOIUrl":null,"url":null,"abstract":"Folliculitis decalvans is a neutrophilic cicatricial alopecia that preferentially affects the scalp vertex and occiput. Therapy aims to arrest inflammation and prevent hair loss. Response to antibiotic and anti-inflammatory treatments is unpredictable, resulting in a sometimes chronic, recalcitrant course. We report three patients with refractory folliculitis decalvans responding to cyclosporin. In the absence of a validated outcome measure for folliculitis decalvans, we considered photographic and symptomatic improvement; maintenance of the same therapeutic dose; and ability to taper therapy in assessing treatment response.","PeriodicalId":243138,"journal":{"name":"The Australasian journal of dermatology","volume":" ","pages":"e345-e347"},"PeriodicalIF":0.0000,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/ajd.13532","citationCount":"1","resultStr":"{\"title\":\"Effective treatment of folliculitis decalvans with cyclosporin: A case series.\",\"authors\":\"Rebekka Jerjen, Nekma Meah, Lara Trindade de Carvalho, Dmitri Wall, Shyamalar Gunatheesan, Rodney Sinclair\",\"doi\":\"10.1111/ajd.13532\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Folliculitis decalvans is a neutrophilic cicatricial alopecia that preferentially affects the scalp vertex and occiput. Therapy aims to arrest inflammation and prevent hair loss. Response to antibiotic and anti-inflammatory treatments is unpredictable, resulting in a sometimes chronic, recalcitrant course. We report three patients with refractory folliculitis decalvans responding to cyclosporin. In the absence of a validated outcome measure for folliculitis decalvans, we considered photographic and symptomatic improvement; maintenance of the same therapeutic dose; and ability to taper therapy in assessing treatment response.\",\"PeriodicalId\":243138,\"journal\":{\"name\":\"The Australasian journal of dermatology\",\"volume\":\" \",\"pages\":\"e345-e347\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1111/ajd.13532\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Australasian journal of dermatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/ajd.13532\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/1/6 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Australasian journal of dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/ajd.13532","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/6 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Effective treatment of folliculitis decalvans with cyclosporin: A case series.
Folliculitis decalvans is a neutrophilic cicatricial alopecia that preferentially affects the scalp vertex and occiput. Therapy aims to arrest inflammation and prevent hair loss. Response to antibiotic and anti-inflammatory treatments is unpredictable, resulting in a sometimes chronic, recalcitrant course. We report three patients with refractory folliculitis decalvans responding to cyclosporin. In the absence of a validated outcome measure for folliculitis decalvans, we considered photographic and symptomatic improvement; maintenance of the same therapeutic dose; and ability to taper therapy in assessing treatment response.